Alembic Pharmaceuticals Limited



Alembic Pharmaceuticals Limited has informed the Exchange regarding ‘Alembic Pharmaceuticals receives USFDA Final Approval for Doxorubicin Hydrochloride Liposome Injection’. |SUBJECT: Updates



Source link

Raj
Author: Raj

Leave a Reply

Your email address will not be published. Required fields are marked *